{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T18:26:01Z","timestamp":1761675961004,"version":"3.40.3"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,6,12]],"date-time":"2012-06-12T00:00:00Z","timestamp":1339459200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2012,6,12]],"date-time":"2012-06-12T00:00:00Z","timestamp":1339459200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>Juvenile idiopathic arthritis (JIA) is characterized by synovial inflammation, followed by hyperplastic changes of the synovium, and destruction of articular cartilage along with underlying bone. This hyperplastic process is the result of inflammation-induced activation of NF-\u03baB, which may be accompanied by decreased osteogenic differentiation of synovial mesenchymal progenitors and contribute to bone resorption. We aimed to explore osteoblast differentiation of synovial fluid (SF)-derived mesenchymal progenitors and correlate it with intensity of inflammation in patients with JIA.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Peripheral blood from 18 patients with oligoarticular (o)JIA, 22 patients with polyarticular (p)JIA and 18 controls was collected along with SF from 18 patients with oJIA and 9 patients with pJIA. SF-derived cells were cultured to assess osteoblastogenesis, using alkaline phosphatase histochemical staining and colorimetric activity assay. The expression of osteoblast-related genes, Runt-related transcription factor 2 (<jats:italic>Runx2<\/jats:italic>), Osteoprotegerin (<jats:italic>OPG<\/jats:italic>), Receptor activator of nuclear factor \u03baB ligand (<jats:italic>RANKL<\/jats:italic>) and arthritis-related cytokine\/chemokine genes, Tumor necrosis factor alpha (<jats:italic>TNF-\u03b1<\/jats:italic>,<jats:italic>Fas<\/jats:italic>, Fas ligand (<jats:italic>FasL<\/jats:italic>), Interleukin (<jats:italic>IL)-1\u03b2<\/jats:italic>,<jats:italic>IL-4<\/jats:italic>,<jats:italic>IL-6<\/jats:italic>,<jats:italic>IL-17<\/jats:italic>,<jats:italic>IL-18<\/jats:italic>, CC chemokine ligand (<jats:italic>CCL)-2<\/jats:italic>,<jats:italic>CCL3<\/jats:italic>,<jats:italic>CCL4<\/jats:italic>was evaluated. Osteoblastogenesis was correlated with systemic and local inflammatory indicators. Expression of osteoblast genes was also analyzed in peripheral blood mononuclear cells (PBMC) and total SF-derived cells from patients with JIA. Additionally, we assessed the inhibitory effect of SF from patients with JIA on differentiation of human bone marrow (hBM)-derived osteoblasts.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Osteoblastogenesis from SF-derived progenitors was decreased in patients with pJIA compared to those with oJIA. Osteoblastogenesis from primary SF-derived cells negatively correlated with erythrocyte sedimentation rate (\u03c1 = -0.391,<jats:italic>P<\/jats:italic>= 0.05), C-reactive protein concentration (\u03c1 = -0.527,<jats:italic>P<\/jats:italic>&lt;0.01) and synovial concentration of IL-17 (\u03c1 = -0.552,<jats:italic>P<\/jats:italic>= 0.01). SF-derived osteoblasts from pJIA patients expressed more<jats:italic>CCL2<\/jats:italic>and<jats:italic>CCL3<\/jats:italic>genes than in oJIA (<jats:italic>P<\/jats:italic>= 0.04 and<jats:italic>P<\/jats:italic>= 0.03, respectively; Mann-Whitney test). Expression of<jats:italic>Fas<\/jats:italic>was significantly higher in osteoblasts from patients with pJIA than those with oJIA (<jats:italic>P<\/jats:italic>= 0.03, Mann-Whitney test). SF-derived cells from patients with pJIA expressed higher levels of<jats:italic>RANKL<\/jats:italic>than in oJIA (<jats:italic>P<\/jats:italic>= 0.05, Mann-Whitney test). PBMCs from patients with JIA expressed less<jats:italic>OPG<\/jats:italic>than healthy control patients (<jats:italic>P<\/jats:italic>= 0.05, Kruskal-Wallis test). SF from all tested JIA patients inhibited differentiation of hBM-derived osteoblasts (<jats:italic>P<\/jats:italic>= 0.04, Kruskal-Wallis test).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Osteoblast differentiation was decreased in patients with severe forms of JIA and accompanied by altered cytokine\/chemokine expression pattern. Development of therapeutic interventions targeting synovial mesenchymal or osteoblast lineage cells in JIA would contribute to alleviating both bone destruction and inflammation in severe forms of the disease.<\/jats:p><\/jats:sec>","DOI":"10.1186\/ar3872","type":"journal-article","created":{"date-parts":[[2012,6,19]],"date-time":"2012-06-19T17:54:54Z","timestamp":1340128494000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Osteoblastogenesis from synovial fluid-derived cells is related to the type and severity of juvenile idiopathic arthritis"],"prefix":"10.1186","volume":"14","author":[{"given":"Elvira","family":"Lazi\u0107","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marija","family":"Jelu\u0161i\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danka","family":"Gr\u010devi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Maru\u0161i\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nata\u0161a","family":"Kova\u010di\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,6,12]]},"reference":[{"key":"3620_CR1","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.berh.2009.12.014","volume":"24","author":"KP Machold","year":"2010","unstructured":"Machold KP: Prevention and cure of rheumatoid arthritis: is it possible?. Best Pract Res Clin Rheumatol. 2010, 24: 353-361. 10.1016\/j.berh.2009.12.014.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"3620_CR2","first-page":"813","volume":"74","author":"T Barr","year":"2008","unstructured":"Barr T, Carmichael NM, S\u00e1ndor GK: Juvenile idiopathic arthritis: a chronic pediatric musculoskeletal condition with significant orofacial manifestations. J Can Dent Assoc. 2008, 74: 813-821.","journal-title":"J Can Dent Assoc"},{"key":"3620_CR3","first-page":"390","volume":"31","author":"RE Petty","year":"2004","unstructured":"Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, He X, Maldonado-Cocco J, Orozco-Alcala J, Prieur AM, Suarez-Almazor ME, Woo P, International League of Associations for Rheumatology: International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision. Edmonton, 2001. J Rheumatol. 2004, 31: 390-392.","journal-title":"J Rheumatol"},{"key":"3620_CR4","first-page":"218","volume-title":"Textbook of pediatric rheumatology","author":"JT Cassidy","year":"2001","unstructured":"Cassidy JT, Petty RE: Juvenile rheumatoid arthritis. Textbook of pediatric rheumatology. Edited by: Cassidy JT, Petty RE. 2001, Philadelphia: WB Saunders, 218-322."},{"key":"3620_CR5","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/nri2062","volume":"7","author":"H Takayanagi","year":"2007","unstructured":"Takayanagi H: Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat Rev Immunol. 2007, 7: 292-304. 10.1038\/nri2062.","journal-title":"Nat Rev Immunol"},{"key":"3620_CR6","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/j.0105-2896.2009.00857.x","volume":"233","author":"NC Walsh","year":"2010","unstructured":"Walsh NC, Gravallese EM: Bone remodeling in rheumatic disease: a question of balance. Immunol Rev. 2010, 233: 301-312. 10.1111\/j.0105-2896.2009.00857.x.","journal-title":"Immunol Rev"},{"key":"3620_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0378-1119(03)00841-2","volume":"321","author":"MS Nanes","year":"2003","unstructured":"Nanes MS: Tumor necrosis factor-alpha: molecular and cellular mechanisms in skeletal pathology. Gene. 2003, 321: 1-15.","journal-title":"Gene"},{"key":"3620_CR8","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1074\/jbc.M106339200","volume":"277","author":"L Gilbert","year":"2002","unstructured":"Gilbert L, He X, Farmer P, Rubin J, Drissi H, van Wijnen AJ, Lian JB, Stein GS, Nanes MS: Expression of the osteoblast differentiation factor RUNX2 (Cbfa1\/AML3\/Pebp2alpha A) is inhibited by tumor necrosis factor-alpha. J Biol Chem. 2002, 277: 2695-2701. 10.1074\/jbc.M106339200.","journal-title":"J Biol Chem"},{"key":"3620_CR9","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1002\/jbmr.5650020612","volume":"2","author":"P Stashenko","year":"1987","unstructured":"Stashenko P, Dewhirst FE, Rooney ML, Desjardins LA, Heeley JD: Interleukin-1 beta is a potent inhibitor of bone formation in vitro. J Bone Miner Res. 1987, 2: 559-565.","journal-title":"J Bone Miner Res"},{"key":"3620_CR10","first-page":"15","volume":"10","author":"L Nguyen","year":"1991","unstructured":"Nguyen L, Dewhirst FE, Hauschka PV, Stashenko P: Interleukin-1 beta stimulates bone resorption and inhibits bone formation in vivo. Lymphokine Cytokine Res. 1991, 10: 15-21.","journal-title":"Lymphokine Cytokine Res"},{"key":"3620_CR11","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1002\/stem.703","volume":"29","author":"L Zhao","year":"2011","unstructured":"Zhao L, Huang J, Zhang H, Wang Y, Matesic LE, Takahata M, Awad H, Chen D, Xing L: Tumor necrosis factor inhibits mesenchymal stem cell differentiation into osteoblasts via the ubiquitin E3 ligase Wwp1. Stem Cells. 2011, 29: 1601-1610. 10.1002\/stem.703.","journal-title":"Stem Cells"},{"key":"3620_CR12","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/nm1538","volume":"13","author":"D Diarra","year":"2007","unstructured":"Diarra D, Stolina M, Polzer K, Zwerina J, Ominsky MS, Dwyer D, Korb A, Smolen J, Hoffmann M, Scheinecker C, van der Heide D, Landewe R, Lacey D, Richards WG, Schett G: Dickkopf-1 is a master regulator of joint remodeling. Nat Med. 2007, 13: 156-163. 10.1038\/nm1538.","journal-title":"Nat Med"},{"key":"3620_CR13","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1359\/jbmr.090305","volume":"24","author":"C Vincent","year":"2009","unstructured":"Vincent C, Findlay DM, Welldon KJ, Wijenayaka AR, Zheng TS, Haynes DR, Fazzalari NL, Evdokiou A, Atkins GJ: Proinflammatory cytokines TNF-related weak inducer of apoptosis (TWEAK) and TNFalpha induce the mitogen-activated protein kinase (MAPK)-dependent expression of sclerostin in human osteoblasts. J Bone Miner Res. 2009, 24: 1434-1449. 10.1359\/jbmr.090305.","journal-title":"J Bone Miner Res"},{"key":"3620_CR14","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1359\/jbmr.090320","volume":"24","author":"NC Walsh","year":"2009","unstructured":"Walsh NC, Reinwald S, Manning CA, Condon KW, Iwata K, Burr DB, Gravallese EM: Osteoblast function is compromised at sites of focal bone erosion in inflammatory arthritis. J Bone Miner Res. 2009, 24: 1572-1585. 10.1359\/jbmr.090320.","journal-title":"J Bone Miner Res"},{"key":"3620_CR15","doi-asserted-by":"publisher","first-page":"3379","DOI":"10.4049\/jimmunol.178.6.3379","volume":"178","author":"N Kova\u010di\u0107","year":"2007","unstructured":"Kova\u010di\u0107 N, Luki\u0107 IK, Gr\u010devi\u0107 D, Katavi\u0107 V, Croucher P, Maru\u0161i\u0107 A: The Fas\/Fas ligand system inhibits differentiation of murine osteoblasts but has a limited role in osteoblast and osteoclast apoptosis. J Immunol. 2007, 178: 3379-3389.","journal-title":"J Immunol"},{"key":"3620_CR16","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1517\/14728222.2010.522347","volume":"14","author":"N Kova\u010di\u0107","year":"2010","unstructured":"Kova\u010di\u0107 N, Gr\u010devi\u0107 D, Katavi\u0107 V, Luki\u0107 IK, Maru\u0161i\u0107 A: Targeting Fas in osteoresorptive disorders. Expert Opin Ther Targets. 2010, 14: 1121-1134. 10.1517\/14728222.2010.522347.","journal-title":"Expert Opin Ther Targets"},{"key":"3620_CR17","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1186\/ar1205","volume":"6","author":"H Tu-Rapp","year":"2004","unstructured":"Tu-Rapp H, Hammerm\u00fcller A, Mix E, Kreutzer HJ, Goerlich R, K\u00f6hler H, Nizze H, Thiesen HJ, Ibrahim SM: A proinflammatory role for Fas in joints of mice with collagen-induced arthritis. Arthritis Res Ther. 2004, 6: 404-414. 10.1186\/ar1205.","journal-title":"Arthritis Res Ther"},{"key":"3620_CR18","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/ar2514","volume":"10","author":"FH Chen","year":"2008","unstructured":"Chen FH, Tuan RS: Mesenchymal stem cells in arthritic diseases. Arthritis Res Ther. 2008, 10: 223-10.1186\/ar2514.","journal-title":"Arthritis Res Ther"},{"key":"3620_CR19","doi-asserted-by":"publisher","first-page":"893","DOI":"10.4065\/84.10.893","volume":"84","author":"AH Undale","year":"2009","unstructured":"Undale AH, Westendorf JJ, Yaszemski MJ, Khosla S: Mesenchymal stem cells for bone repair and metabolic bone diseases. Mayo Clin Proc. 2009, 84: 893-902. 10.4065\/84.10.893.","journal-title":"Mayo Clin Proc"},{"key":"3620_CR20","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1002\/art.21212","volume":"52","author":"Y Sakaguchi","year":"2005","unstructured":"Sakaguchi Y, Sekiya I, Yagishita K, Muneta T: Comparison of human stem cells derived from various mesenchymal tissues: superiority of synovium as a cell source. Arthritis Rheum. 2005, 52: 2521-2529. 10.1002\/art.21212.","journal-title":"Arthritis Rheum"},{"key":"3620_CR21","doi-asserted-by":"publisher","first-page":"17432","DOI":"10.1073\/pnas.0607939103","volume":"103","author":"X Li","year":"2006","unstructured":"Li X, Makarov SS: An essential role of NF-kappaB in the \"tumor-like\" phenotype of arthritic synoviocytes. Proc Natl Acad Sci USA. 2006, 103: 17432-17437. 10.1073\/pnas.0607939103.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3620_CR22","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1152\/ajpendo.00534.2004","volume":"288","author":"LC Gilbert","year":"2005","unstructured":"Gilbert LC, Rubin J, Nanes MS: The p55 TNF receptor mediates TNF inhibition of osteoblast differentiation independently of apoptosis. Am J Physiol Endocrinol Metab. 2005, 288: 1011-1018.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"3620_CR23","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/bdrc.20043","volume":"75","author":"ED Jensen","year":"2005","unstructured":"Jensen ED, Westendorf JJ: Runx2: a master organizer of gene transcription in developing and maturing osteoblasts. Birth Defects Res C Embryo Today. 2005, 75: 213-225. 10.1002\/bdrc.20043.","journal-title":"Birth Defects Res C Embryo Today"},{"key":"3620_CR24","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.4049\/jimmunol.170.5.2655","volume":"170","author":"E Lubberts","year":"2003","unstructured":"Lubberts E, van den Bersselaar L, Oppers-Walgreen B, Schwarzenberger P, Coenen-de Roo CJ, Kolls JK, Joosten LA, van den Berg WB: IL-17 promotes bone erosion in murine collagen-induced arthritis through loss of the receptor activator of NF-kappa B ligand\/osteoprotegerin balance. J Immunol. 2003, 170: 2655-2662.","journal-title":"J Immunol"},{"issue":"Suppl 3","key":"3620_CR25","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/ard.2006.058529","volume":"65","author":"MI Koenders","year":"2006","unstructured":"Koenders MI, Joosten LA, van den Berg WB: Potential new targets in arthritis therapy: interleukin (IL)-17 and its relation to tumour necrosis factor and IL-1 in experimental arthritis. Ann Rheum Dis. 2006, 65 (Suppl 3): 29-33.","journal-title":"Ann Rheum Dis"},{"key":"3620_CR26","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1002\/jbmr.1488","volume":"27","author":"M Rauner","year":"2012","unstructured":"Rauner M, Stein N, Winzer M, Goettsch C, Zwerina J, Schett G, Distler JH, Albers J, Schulze J, Schinke T, Bornh\u00e4user M, Platzbecker U, Hofbauer LC: WNT5A is induced by inflammatory mediators in bone marrow stromal cells and regulates cytokine and chemokine production. J Bone Miner Res. 2012, 27: 575-85. 10.1002\/jbmr.1488.","journal-title":"J Bone Miner Res"},{"key":"3620_CR27","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","volume":"93","author":"DL Lacey","year":"1998","unstructured":"Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliot R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ: Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell. 1998, 93: 165-176. 10.1016\/S0092-8674(00)81569-X.","journal-title":"Cell"},{"key":"3620_CR28","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","volume":"89","author":"WS Simonet","year":"1997","unstructured":"Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Sander S, Van G, Tarpley J, Derby P, Lee R, Boyle WJ: Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell. 1997, 89: 309-319. 10.1016\/S0092-8674(00)80209-3.","journal-title":"Cell"},{"key":"3620_CR29","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/35046102","volume":"408","author":"H Takayanagi","year":"2000","unstructured":"Takayanagi H, Ogasawara K, Hida S, Chiba T, Murata S, Sato K, Takaoka A, Yokochi T, Oda H, Tanaka K, Nakamura K, Taniguchi T: T-cell-mediated regulation of osteoclastogenesis by signaling cross-talk between RANKL and IFN-gamma. Nature. 2000, 408: 600-605. 10.1038\/35046102.","journal-title":"Nature"},{"key":"3620_CR30","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1546-0096-8-30","volume":"8","author":"G Lien","year":"2010","unstructured":"Lien G, Ueland T, Godang K, Selvaag AM, F\u00f8rre OT, Flat\u00f8 B: Serum levels of osteoprotegerin and receptor activator of nuclear factor -\u03baB ligand in children with early juvenile idiopathic arthritis: a 2-year prospective controlled study. Pediatr Rheumatol Online J. 2010, 8: 30-10.1186\/1546-0096-8-30.","journal-title":"Pediatr Rheumatol Online J"},{"key":"3620_CR31","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/nrendo.2010.190","volume":"6","author":"G Schett","year":"2010","unstructured":"Schett G, David JP: The multiple faces of autoimmune-mediated bone loss. Nat Rev Endocrinol. 2010, 6: 698-706. 10.1038\/nrendo.2010.190.","journal-title":"Nat Rev Endocrinol"},{"key":"3620_CR32","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1093\/rheumatology\/40.5.522","volume":"40","author":"MC Honorati","year":"2001","unstructured":"Honorati MC, Meliconi R, Pulsatelli L, Cane S, Frizziero L, Facchini A: High in vivo expression of interleukin-17 receptor in synovial endothelial cells and chondrocytes from arthritis patients. Rheumatology. 2001, 40: 522-527. 10.1093\/rheumatology\/40.5.522.","journal-title":"Rheumatology"},{"key":"3620_CR33","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1002\/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E","volume":"42","author":"M Chabaud","year":"1999","unstructured":"Chabaud M, Durand JM, Buchs N, Fossiez F, Page G, Frappart L, Miossec P: Human interleukin-17: a T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum. 1999, 42: 963-970. 10.1002\/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E.","journal-title":"Arthritis Rheum"},{"key":"3620_CR34","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1002\/art.23291","volume":"58","author":"K Nistala","year":"2008","unstructured":"Nistala K, Moncrieffe H, Newton KR, Varsani H, Hunter P, Wedderburn LR: Interleukin-17-producing T cells are enriched in the joints of children with arthritis, but have a reciprocal relationship to regulatory T cell numbers. Arthritis Rheum. 2008, 58: 875-887. 10.1002\/art.23291.","journal-title":"Arthritis Rheum"},{"key":"3620_CR35","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1182\/blood-2007-02-069716","volume":"110","author":"AJ Nauta","year":"2007","unstructured":"Nauta AJ, Fibbe WE: Immunomodulatory properties of mesenchymal stromal cells. Blood. 2007, 110: 3499-3506. 10.1182\/blood-2007-02-069716.","journal-title":"Blood"},{"key":"3620_CR36","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1002\/jcp.21839","volume":"221","author":"G Lisignoli","year":"2009","unstructured":"Lisignoli G, Manferdini C, Codeluppi K, Piacentini A, Grassi F, Cattini L, Filardo G, Facchini A: CCL20\/CCR6 chemokine\/receptor expression in bone tissue from osteoarthritis and rheumatoid arthritis patients: different response of osteoblasts in the two groups. J Cell Physiol. 2009, 221: 154-160. 10.1002\/jcp.21839.","journal-title":"J Cell Physiol"},{"key":"3620_CR37","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1002\/1529-0131(200006)43:6<1266::AID-ANR9>3.0.CO;2-P","volume":"43","author":"Z Szekanecz","year":"2000","unstructured":"Szekanecz Z, Halloran MM, Volin MV, Woods JM, Strieter RM, Kenneth Haines G, Kunkel SL, Burdick MD, Koch AE: Temporal expression of inflammatory cytokines and chemokines in rat adjuvant-induced arthritis. Arthritis Rheum. 2000, 43: 1266-1277. 10.1002\/1529-0131(200006)43:6<1266::AID-ANR9>3.0.CO;2-P.","journal-title":"Arthritis Rheum"},{"key":"3620_CR38","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1517\/14728222.2010.522347","volume":"14","author":"N Kova\u010di\u0107","year":"2010","unstructured":"Kova\u010di\u0107 N, Gr\u010devi\u0107 D, Katavi\u0107 V, Luki\u0107 IK, Maru\u0161i\u0107 A: Targeting Fas in osteoresorptive disorders. Expert Opin Ther Targets. 2010, 14: 1121-1134. 10.1517\/14728222.2010.522347.","journal-title":"Expert Opin Ther Targets"},{"key":"3620_CR39","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s10067-008-0985-y","volume":"28","author":"VF Caparbo","year":"2009","unstructured":"Caparbo VF, Prada F, Silva CA, Regio PL, Pereira RM: Serum from children with polyarticular juvenile idiopathic arthritis (pJIA) inhibits differentiation, mineralization and may increase apoptosis of human osteoblasts \"in vitro\". Clin Rheumatol. 2009, 28: 71-77. 10.1007\/s10067-008-0985-y.","journal-title":"Clin Rheumatol"},{"key":"3620_CR40","first-page":"251","volume":"17","author":"RM Pereira","year":"1999","unstructured":"Pereira RM, Falco V, Corrente JE, Chahade WH, Yoshinari NH: Abnormalities in biochemical markers of bone turnover in children with juvenile chronic arthritis. Clin Exp Rheumatol. 1999, 17: 251-255.","journal-title":"Clin Exp Rheumatol"},{"key":"3620_CR41","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/BF03347283","volume":"21","author":"F Falcini","year":"1998","unstructured":"Falcini F, Ermini M, Bagnoli F: Bone turnover is reduced in children with juvenile rheumatoid arthritis. J Endocrinol Invest. 1998, 21: 31-36.","journal-title":"J Endocrinol Invest"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar3872.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/ar3872\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar3872.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T05:49:15Z","timestamp":1743572955000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/ar3872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,12]]},"references-count":41,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2012,6]]}},"alternative-id":["3620"],"URL":"https:\/\/doi.org\/10.1186\/ar3872","relation":{},"ISSN":["1478-6354"],"issn-type":[{"type":"electronic","value":"1478-6354"}],"subject":[],"published":{"date-parts":[[2012,6,12]]},"assertion":[{"value":"17 January 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2012","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2012","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2012","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R139"}}